Biotech Values

[iOwnSomeBio]

"It’s as rkrw surmised in #22376: Goldberg says that MNTA is barking up the wrong tree because oral heparin will make all the injectable products irrelevant. It follow that Goldberg must think LMW heparins confer no significant advantage versus ordinary (unfractionated) heparin and, indeed, that’s what Goldberg has asserted."

Goldberg is misinformed to think LMWH has no advantage over UFH. Also, LMWH is only 1 of MNTA's products...MNTA has a diverse portfolio and does not have all its eggs in one basket.